Photocure ASA: Change of Board Composition

The nomination committee has initiated a search for a new Chairperson, and it is expected that the committee will present its recommendations to the annual general meeting in 2024 at the latest. The nomination committee has initiated a search for a new Chairperson, and it is expected that the committee will present its recommendations to the annual general meeting in 2024 at the latest. For further information, please contact: Erik DahlChief Financial Officer Email:ed@photocure...

The nomination committee has initiated a search for a new Chairperson, and it is expected that the committee will present its recommendations to the annual general meeting in 2024 at the latest.

For further information, please contact:

Erik Dahl
Chief Financial Officer
Email: ed@photocure.com

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com 

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/photocure-asa-change-of-board-composition-301940700.html